← Open Payments lookup

DAVID LINDEN: Open Payments

NPI 1821062324 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,876 in 85 payments from 13 companies in 2025. Trend: 2023 $1,257 · 2024 $1,806 · 2025 $1,876

Food & beverage: $1,876
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.17$437
Otsuka America Pharmaceutical, Inc.20$370
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$254
Alkermes, Inc.8$218
Lundbeck LLC11$160
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$89
Teva Pharmaceuticals USA, Inc.5$76
Janssen Pharmaceuticals, Inc4$70
Forte Bio-Pharma LLC3$55
Neurocrine BioSciences, Inc.2$46

Products named: REXULTI, COBENFY, CAPLYTA, ARISTADA, RELISTOR, UZEDY, INGREZZA, LOREEV XR.

Industry payments across NV — which companies pay providers there.